Showing results (261-270 of 481) with videos related to
Sort By:
Pageof 49
BJU International|April 17, 2012
Practice-setting and surgeon characteristics heavily influence the decision to perform partial nephrectomy among American Urologic Association surgeonsChristopher J Weight, Paul L Crispen, Rodney H Breau, et al.Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|October 11, 2019
Survival outcomes for patients with surgically induced end-stage renal diseaseBimal Bhindi, Dennis Asante, Megan E Branda, et al.The Journal of Urology|June 2, 2018
The Association of Aspirin Use with Survival Following Radical CystectomyTimothy D Lyon, Igor Frank, Paras H Shah, et al.Pathology|August 27, 2015
High grade neuroendocrine carcinoma of the urinary bladder treated by radical cystectomy: a series of small cell, mixed neuroendocrine and large cell neuroendocrine carcinomaSounak Gupta, R Houston Thompson, Stephen A Boorjian, et al.Journal of Proteomics|March 14, 2019
An inter-subunit protein-peptide interface that stabilizes the specific activity and oligomerization of the AAA+ chaperone ReptinDominika Coufalova, Lucy Remnant, Lenka Hernychova, et al.Mayo Clinic Proceedings|July 31, 2025
The Impact of Open Surgical Team Consistency on Oncologic and Functional Outcomes Following Radical ProstatectomyFrancis A Jefferson, Stephen A Boorjian, Prabin Thapa, et al.Urologic Oncology|June 11, 2018
Temporal trends in venous thromboembolism after radical cystectomyTimothy D Lyon, Matthew K Tollefson, Paras H Shah, et al.The Neuroradiology Journal|June 19, 2019
Evidence for sex differences in morphological abnormalities in type I Chiari malformationJames R Houston, Natalie J Allen, Maggie S Eppelheimer, et al.Cancer|May 17, 2005
Reclassification of patients with pT3 and pT4 renal cell carcinoma improves prognostic accuracyR Houston Thompson, John C Cheville, Christine M Lohse, et al.World Journal of Urology|May 17, 2014
Cancer-specific mortality following radical cystectomy for bladder cancer with lymph node involvement: impact of pathologic disease features and adjuvant chemotherapyMarisa M Clifton, Sarah P Psutka, Stephen A Boorjian, et al.Pageof 49